“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant

A new era in transplantation is here. Roswell Park reports a remarkable 92.6% one-year survival rate following allogeneic transplant—well above the national average—thanks to evidence-based innovations transforming patient care.

July 8, 2026

Roswell Park Comprehensive Cancer Center

1

Roswell Park Comprehensive Cancer Center reports a 92.6% one-year survival rate following allogeneic transplants, surpassing the national average of 80%.
2

The center has adopted new practices, including reduced IV fluid and antibiotic use, to improve patient outcomes and streamline transplant procedures.
3

Transplantation eligibility has expanded to include liquid tumor patients up to age 85 and those with non-perfect match donors.
4

Operational consistency and deliberate donor selection strategies have been shown to significantly enhance outcomes for transplant patients.
5

Dr. Holtan emphasizes the importance of minimizing patient travel burdens and costs to improve access to potentially curative transplant therapies.

“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant

1

2

3

4

5

Original Source(s)

“New Era for Transplants”: Roswell Park Reports Increased Survival Outcomes One Year Following Allogeneic Transplant

Related Content

Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Post–Acute Care Facility Utilization and Outcomes Among Medicare Beneficiaries Undergoing Inpatient Cancer

Can Immunopeptidomics Redefine Cancer Immunotherapy Development?